Treatment of Pulmonary Sarcoidosis With Pentoxifylline

NCT00001877 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

100

Enrollment

NIH

Sponsor class

Conditions

Pulmonary Sarcoidosis

Interventions

DRUG: Pentoxifylline

Sponsor

National Heart, Lung, and Blood Institute (NHLBI)